Page 455 - medicina-integrativa_compress
P. 455

456     PARTE II,  SECCIÓN 6 TRASTORNOS METABÓLICOS Y ENDOCRINOS

           52. Gardner CD, Coulston A, Chatterjee L, et al: The effect of a plant-  60. Nestel PJ: Fish oil and cardiovascular disease: Lipids and arterial
              based diet on plasma lipids in hypercholesterolemic adults. Ann  function. Am J Clin Nutr 71(Suppl):228S-231S, 2000.
              Intern Med 142:725-733, 2005.                    61. Laidlaw M, Holub BJ: Effects of supplementation with fish
           53. Jenkins DJA, Kendall CWC, Marchie A, et al: Effects of a dietary  oil-derived n-3 fatty acids and gamma-linolenic acid on circulating
              portfolio of cholesterol-lowering foods versus lovastatin on serum  plasma lipids and fatty acid profiles in women. Am J Clin Nutr
              lipids and C-reactive protein. JAMA 290:502-510, 2003.  77:37-42, 2003.
           54. Jenkins DJA, Kendall CWC, Marchie A, et al: Direct comparison   62. Gouni-Berthold I, Berthold HK: Policosanol: Clinical pharmacology
              of a dietary portfolio of cholesterol-lowering foods with a statin in  and therapeutic significance of a new lipid-lowering agent. Am Heart
              hypercholesterolemic participants. Am J Clin Nutr 81:380-387. 2005.  J 143:356-365, 2002.
           55. Lichtenstein AH, Deckelbaum RJ: Stanol/sterol ester-containing foods  63. Berthold HK, Unverdorben S, Degenhardt R, et al: Effect of
              and blood cholesterol levels. Circulation 103:1177-1179, 2001.  policosanol on lipid levels among patients with hypercholestendemia
           56. Chen JT, Wesley R, Shamburek RD, et al: Meta-analysis of natural  or combined hyperlipidemia. JAMA 295:2262-2269, 2006.
              therapies for hyperlipidemia: Plant sterols and stanols versus  64. Castano G, Mas R, Fernandez L, et al: Effects of policosanol 20 versus
              policosanol. Pharmacotherapy 25:171-183, 2005.      40 mg/day in the treatment of people with type II
           57. Cater NB: Plant stanol ester: Review of cholesterol-lowering efficacy  hypercholesterolemia: A 6-month double-blind study. Int J Clin
              and implications for coronary heart disease risk reduction. Prev  Pharmacol Res 21:43-57, 2001.
              Cardiol 3:121-130, 2000.                         65. Szapary PO, Rader DJ, DerMarderosian A: Guggulipid and
           58. Anderson JW, Davidson MH, Blonde L, et al: Long-term cholesterol-  cholesterol levels [Letter]. JAMA 290:2800-2801, 2003.
              lowering effects of psyllium as an adjunct to diet therapy in the  66. Szapary PO, Wolfe ML, Bloedon LT, et al: Guggulipid for the
              treatment of hypercholesterolemia. Am J Clin Nutr 71:1433-1438,  treatment of hypercholesterolemia: A randomized controlled trial.
              2000.                                               JAMA 290:765-772, 2003.
           59. Moreyra AE, Wilson AC, Koraym A: Effect of combining psyllium  67. Heber D, Ashley JM, Elashoff DA, et al: Cholesterol-lowering effects
              fiber with simvastatin in lowering cholesterol. Arch Intern Med  of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin
              165:1161-1166, 2005.                                Nutr 69:231-236, 1999.
   450   451   452   453   454   455   456   457   458   459   460